Skip to main content
Signal8

Tomsche David Scott

SEC insider (Form 3/4/5 filer). CIK 0001384044. Director at IMMUCELL CORP /DE/ (ICCC). 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 15, 2026. Located in PORTLAND, ME.

Companies Tomsche David Scott has filed insider reports for

  • IMMUCELL CORP /DE/ (ICCC): Director
Tomsche David Scott profile photo

Tomsche David Scott

CIK: 0001384044

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMMUCELL CORP /DE/ logo
ICCC

IMMUCELL CORP /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Apr 15, 2026
    Award

    Non Qualified Stock Options (Right to buy)

    Direct
    11.9K shares-
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Nov 25, 2025
    Purchase
    Direct
    1.6K shares at avg. $4.76$8K
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Nov 25, 2025
    Purchase
    Indirect
    1.6K shares at avg. $4.76$8K
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Apr 16, 2025
    Award

    Non Qualified Stock Options (Right to buy)

    Direct
    10K shares-
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Sep 20, 2024
    Award

    Non Qualified Stock Options (Right to buy)

    Direct
    10K shares at avg. $3.60-

1-5 of 5